Nav: Home

UQ opens new era in cancer research and drug development

March 28, 2017

New cancer-fighting drugs and devices could emerge from The University of Queensland, thanks to a research program comparing cancers in pet animals and humans in a state-of-the-art imaging facility opened today.

UQ Centre for Advanced Imaging (CAI) director Professor David Reutens said the new Australian Cancer Research Foundation (ACRF) Facility for Molecular Imaging Agents in Cancer opened a new paradigm in comparative oncology.

"It will allow researchers to examine the effects of tiny doses of anti-cancer drugs in human and animal cancers," he said.

"The facility will build on the long-term development of world-class facilities in health and medical bioscience and research in Queensland, linking with other imaging capabilities such as the Herston Imaging Research Facility and the Translational Research Institute's Innovation and Translation Centre."

A $2.5 million Australian Cancer Research Foundation grant has enabled the purchase of a large-bore PET-CT scanner and an upgrade of the CAI's magnetic resonance imaging facilities.

"We are using molecular imaging to improve cancer detection, characterisation, treatment and monitoring," he said.

Professor Reutens said the centre would run Australia's first comparative oncology research program, studying naturally occurring cancers in companion animals such as dogs to learn more about treating cancer in humans.

"This will help develop new drugs, devices and imaging procedures for human patients," he said.

"The new facility will enhance the success of clinical trials on human cancer therapies."

Australian Cancer Research Foundation CEO Professor Ian Brown said the ACRF Facility for Molecular Imaging Agents in Cancer offered a new opportunity to better understand cancer in its many forms.

"It provides a chance for the development of new approaches for the prevention, detection and treatment of cancer," he said.

"The ACRF supporters who made this grant possible know that the investment in state-of-the-art technology when placed in the hands of the best researchers will lead to the breakthroughs that we all desire."

"Researchers in Australia are among the best in the world, and we're delighted to be supporting the cutting-edge work of the teams working together at UQ.

"Research and innovation are our best means of finding ways to end cancer."

University of Queensland

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".